Nanotherapeutics is an advancing technology and promising industry of the
21st century; with further development, it may hold secrets for the medical community
and society as a whole. The development of nanotherapeutics into medicine is one of
the newest developments in medical science that the scientific community has taken.
The conventional approach of delivering anticancer drugs towards the targeted site is
remained controversial and has numerous problems such as non-specific effects to the
surrounding organs other than cancer affected, anticancer drug resistance, and chronic
adverse effects. Recently, biomedical scientists have turned their attention towards
nanocarriers possessing incredible activity to deliver anticancer drugs towards canceraffected
areas without being disrupted by endogenous barriers, rendering lesser toxicity
and promoting anticancer response. In this chapter, the overview of nanotherapeutic
agents is thoroughly assessed in the treatment of cancers.
Keywords: Anticancer Drugs, Cancer, Nanotherapeutics, Resistance, Toxicity, Targeted Delivery.
